Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

After FuelCell Lost Its Momentum, Avoid FCEL Stock

By Chris Lau, InvestorPlace Contributor

FuelCell stock faces unbreakable negative momentum that may send FCEL stock tumbling back to last year’s lows.

7 SaaS Stocks Powering an Interconnected World

By Chris Lau, InvestorPlace Contributor

The Interconnected World will grow post-pandemic as companies embrace cloud-based software solutions. You should consider SaaS stocks too.

Avoid Discovery Stock Until the Major Selling Overhang Eases

By Chris Lau, InvestorPlace Contributor

Discovery rose in weeks only to fall suddenly, creating a shock that threatens to send the stock back to multi-year lows.

Despite Its Recent Weakness, C3.ai Stock Is Worth Another Look

By Chris Lau, InvestorPlace Contributor

C3.ai has multiple long-term catalysts ahead, but AI stock will remain volatile until the company becomes profitable. That's not expected to happen soon.

Skillz Has To Prove Itself to Investors Right Now

By Chris Lau, InvestorPlace Contributor

SKLZ stock is under pressure after booking high costs in the the fourth quarter of 2020 despite a gaming market that remained red hot.

Load More